AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Nvidia on verge of completing $700 million acquisition of Run:ai
2
Nvidia announces $700 million acquisition of Run:ai
3
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
4
Nagomi Security raises $23 million Series A for proactive defense platform
5
Bill Ackman: "Israel needs support more than ever and I can help"
More news

U.S.

20 stories about U.S.
מטה חברת טבע תרופות

Teva Part of $50 Billion Opioid Settlement Deal, Report Says

17.10.19|Hezi Sternlicht
Teva, a second drugmaker, and the three largest drug distributors in the U.S. have agreed with multiple states on a settlement framework ahead of Monday’s trial, the New York Times reported Thursday
אתר טבע כפר סבא

Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says

16.10.19|Hezi Sternlicht
The Israeli drugmaker and several other drug distributors are set to face around 2,500 lawsuits related to the U.S. opioid abuse epidemic in just a week at a Cleveland, Ohio federal court
מטה חברת טבע תרופות

Judge Rejects Teva’s Request to Be Tried Separately in U.S. Opioid Case, Report Says

13.10.19|CTech
Teva made a last minute attempt to be tried separately in opioid abuse damages case set to be held on October 21 in federal court in Cleveland, Ohio
חברת תרופות אלרגן

Allergan Says Teva Bears Sole Liability for Actavis' Actions

02.09.19|Hezi Sternlicht
Actavis, which Teva bought from Allergan in 2016 for $40.5 billion, was one of the top U.S. sellers of opioids in 2006-2012
אתר טבע כפר סבא

Teva Faces New Opioid-Related Lawsuit in West Virginia

25.08.19|Hezi Sternlicht
The lawsuit seems to be unrelated to the trial set to start against Teva and other opioid manufacturers in October in Ohio federal court
מטה חברת טבע תרופות

Teva Jumps on NYSE on a Bit of Good News

21.08.19|Hezi Sternlicht
An opioid-abuse lawsuit settlement reached by drugmakers Endo and Allergan Tuesday could bode well for Teva’s legal future, as does the release of an FDA-approved generic version of EpiPen JR
אורי יהודאי

IFF Submits Frutarom Findings to U.S. Department of Justice

13.08.19|Tomer Ganon and Ran Abramson
While the company claimed it was only made aware of Frutarom's allegedly improper actions recently, one person familiar with the matter told Calcalist IFF was made aware of the matter during the due diligence process
מוסף שבועי 6.6.19 ויקטור וקסלברג

Following U.S. Sanctions, Israeli Cybersecurity Company Renounces Once-Boasted Ties to Russian Oligarch

30.07.19|Tomer Ganon, Hagar Ravet, Amir Kurz, and Ran Abramson
Russian businessman Viktor Vekselberg invested $13 million in Tel Aviv-based cybersecurity company Deep Instinct through investment fund IVCP, a 13.9% stake now worth around $28.5 million
אהרון אהרון מנכ"ל רשות החדשנות 17.4.19

BIRD Foundation to Invest $8.2 Million in Nine Joint U.S.-Israeli Projects

07.07.19|Adi Pick
The projects, which are in a variety of technological fields including agtech, medical devices, and digital health, have been vetted by the Israeli government’s tech investment arm the Israel Innovation Authority
שדה סולארי לוחות סולאריים אנרגיה ירוקה

Huawei Enters Israeli Solar Electricity Market

27.06.19|Lior Gutman
The Chinese telecommunications company has made a strategic decision to open a local representation to sell equipment to solar energy companies, following reports that it was shutting down its energy operations in the U.S.
אתר טבע כפר סבא

Court Approves One Teva Opioid Settlement, Many More to Come

25.06.19|Hezi Sternlicht
The settlement will see Teva will pay Oklahoma a one-time payment of $85 million to settle claims that it had played a role in exacerbating the U.S. opioid use epidemic there
דיוויד פרידמן טקס ב שגרירות ארה"ב ב ירושלים

Israeli Police Investigate Claim That Local Winery Scammed U.S. Ambassador

12.06.19|Tomer Ganon
In December, Calcalist reported that New York-based wine investment company Karraben Wine, previously owned by Ambassador David Friedman, sued an Israeli winery for fraud
מטה חברת טבע תרופות

Teva Reaches $85 Million Settlement in Oklahoma Opioid Damages Suit

27.05.19|Hezi Sternlicht
Teva is one of several opioid manufacturers being sued in the U.S. by different states and private entities for its alleged role in the nation's opioid addiction crisis
אנרגיה מתחדשת ירוקה MIT חדשנות יזמות

U.S., Israel Issue Call for Energy and Water-Related Joint Tech Proposals

23.05.19|Adi Pick
Four awards are available, one in each of the domains of fossil energy, energy storage, energy-water nexus, and energy cyber and physical security in critical infrastructure, via The U.S.-Israel Energy Center
מרכז המחקר והפיתוח של וואווי בהוד השרון טוגה נטוורקס

Huawei Temporarily Suspends Israeli Employees With U.S. Citizenship

22.05.19|Omer Kabir
According to information obtained by Calcalist, the policy was not Israel-specific but rather implemented by Huawei globally wherever it has employees of American nationality
יו"ר הפד לשעבר ג'נט ילן באוניברסיטת תל אביב

Trump’s Political Agenda Could Threaten Independence of Federal Reserve, Says Former Chair

19.05.19|Uri Pasovsky
Economist Janet Yellen spoke at a symposium held at Tel Aviv University, from which she received an honorary doctorate Thursday
מטה חברת טבע תרופות

Teva’s Shady Legal Past Still Weighs on the Debt-Laden Pharma Company

12.05.19|Hezi Sternlicht
On Friday, 43 states joined Connecticut in filing a lawsuit against senior Teva executives and against over a dozen former and current senior executives at leading generic drug companies, alleging all were involved in a drug price-fixing conspiracy
אסדת קידוח אנרג'יאן מאגר גז כריש 2

BIRD Foundation Seeks Joint Israel-U.S. Energy-Focused R&D Projects

30.04.19|CTech
Each project selected will receive a grant of up to 50% of its R&D costs, at a maximum sum of $1 million
יפעת אורון מנכ"לית לאומיטק ועידת ניו יורק 2019

Israel May Soon Have to Choose Between The U.S. and China, Says LeumiTech CEO

14.04.19|Adi Pick
Yifat Oron spoke at Calcalist’s Mind the Tech conference in New York
מנהטן ניו יורק

Israeli Citizens to Become Eligible for U.S. Investor Visas as of May

24.03.19|Gad Lior and Adi Pick
Known as the E-2 visa, the investor visa will provide Israeli citizens willing to commit to a substantial investment in the U.S. resulting in the hiring of U.S. citizens with work permits
Previous ArticlesMore Articles